1.Role of Innate Immunity in the Pathogenesis of Type 1 and Type 2 Diabetes.
Journal of Korean Medical Science 2014;29(8):1038-1041
The importance of innate immunity in host defense is becoming clear after discovery of innate immune receptors such as Toll-like receptor or Nod-like receptor. Innate immune system plays an important role in diverse pathological situations such as autoimmune diseases. Role of innate immunity in the pathogenesis of metabolic disorders such as type 2 diabetes, metabolic syndrome or atherosclerosis that has not been previously considered as inflammatory disorders, is also being appreciated. Here, the role of innate immunity in the development of type 1 diabetes, a classical organ-specific autoimmune disease, and type 2 diabetes will be discussed, focusing on the role of specific innate immune receptors involved in these disease processes.
Animals
;
Cytokines/*immunology
;
Diabetes Mellitus, Type 1/*immunology
;
Diabetes Mellitus, Type 2/*immunology
;
Humans
;
Immunity, Innate/*immunology
;
Inflammasomes/*immunology
;
*Models, Immunological
;
Pancreas/immunology
2.Regulation of HMGB1 release by inflammasomes.
Ben LU ; Haichao WANG ; Ulf ANDERSSON ; Kevin J TRACEY
Protein & Cell 2013;4(3):163-167
High mobility group box 1 (HMGB1) is an evolutionarily conserved non-histone chromatin-binding protein. During infection or injury, activated immune cells and damaged cells release HMGB1 into the extracellular space, where HMGB1 functions as a proinflammatory mediator and contributes importantly to the pathogenesis of inflammatory diseases. Recent studies reveal that inflammasomes, intracellular protein complexes, critically regulate HMGB1 release from activated immune cells in response to a variety of exogenous and endogenous danger signals. Double stranded RNA dependent kinase (PKR), an intracellular danger-sensing molecule, physically interacts with inflammasome components and is important for inflammasome activation and HMGB1 release. Together, these studies not only unravel novel mechanisms of HMGB1 release during inflammation, but also provide potential therapeutic targets to treat HMGB1-related inflammatory diseases.
HMGB1 Protein
;
chemistry
;
metabolism
;
Humans
;
Inflammasomes
;
metabolism
;
Macrophages
;
immunology
;
metabolism
;
eIF-2 Kinase
;
metabolism
3.Research advances of inflammasome and its role in sepsis.
Journal of Zhejiang University. Medical sciences 2010;39(5):487-492
Inflammasomes are high-molecular-weight, multiprotein complexes in cells, which are assembled after cytoplasmic nucleotide-binding oligomerization domain like receptors (NLRs) sense pathogens and danger signals. The inflammasome can activate caspase-1, and later makes the pro-IL-1β, proIL-18 precursor mature by cleavaging, thereby mediates the innate immunity. Dysregulation of inflammasomes plays an important role in the development of sepsis and other immune inflammatory diseases, thus inflammasome may be a new target for prevention and treatment of sepsis.
Caspase 1
;
immunology
;
metabolism
;
Humans
;
Inflammasomes
;
chemistry
;
immunology
;
metabolism
;
Interleukin-18
;
immunology
;
metabolism
;
Interleukin-1beta
;
immunology
;
metabolism
;
Sepsis
;
immunology
;
metabolism
;
Signal Transduction
4.Inflammasomes in cancer: a double-edged sword.
Ryan KOLB ; Guang-Hui LIU ; Ann M JANOWSKI ; Fayyaz S SUTTERWALA ; Weizhou ZHANG
Protein & Cell 2014;5(1):12-20
Chronic inflammatory responses have long been observed to be associated with various types of cancer and play decisive roles at different stages of cancer development. Inflammasomes, which are potent inducers of interleukin (IL)-1β and IL-18 during inflammation, are large protein complexes typically consisting of a Nod-like receptor (NLR), the adapter protein ASC, and Caspase-1. During malignant transformation or cancer therapy, the inflammasomes are postulated to become activated in response to danger signals arising from the tumors or from therapy-induced damage to the tumor or healthy tissue. The activation of inflammasomes plays diverse and sometimes contrasting roles in cancer promotion and therapy depending on the specific context. Here we summarize the role of different inflammasome complexes in cancer progression and therapy. Inflammasome components and pathways may provide novel targets to treat certain types of cancer; however, using such agents should be cautiously evaluated due to the complex roles that inflammasomes and pro-inflammatory cytokines play in immunity.
Animals
;
Carcinoma
;
immunology
;
pathology
;
therapy
;
Gastrointestinal Neoplasms
;
immunology
;
pathology
;
therapy
;
Humans
;
Inflammasomes
;
metabolism
;
Melanoma
;
immunology
;
pathology
;
therapy
;
Neoplasms
;
immunology
;
pathology
;
therapy
;
Skin Neoplasms
;
immunology
;
pathology
;
therapy
5.Inflammasome and its role in immunological and inflammatory response at early stage of burns.
Fang ZHANG ; Jiahui LI ; Zhaofan XIA
Chinese Journal of Burns 2014;30(3):261-264
Inflammasomes are large multi-protein complexes that serve as a platform for caspase-1 activation, and this process induces subsequent maturation and secretion of the proinflammatory cytokines IL-1β and IL-18, as well as pyroptosis. As an important component of the innate immune system, early activation of inflammasomes in a variety of immune cell subsets can mediate inflammatory response and immunological conditions after burn injury. Here, we review the current knowledge of inflammasomes and its role in immunological and inflammatory response at the early stage of burn injury.
Apoptosis
;
Burns
;
immunology
;
Caspase 1
;
metabolism
;
Cytokines
;
Humans
;
Inflammasomes
;
physiology
;
Inflammation Mediators
;
immunology
;
Interleukin-18
;
immunology
;
physiology
;
Interleukin-1beta
;
immunology
;
physiology
6.Investigation of inflammasome during excitation of IgG-HepG2 cells for evaluation of allergenic ingredients.
Xi LU ; Mingwei WANG ; Fan LEI ; Yugang WANG ; Zhiyi YUAN ; Shuang ZHAO ; Huiyu LI ; Dongming XING ; Lijun DU
China Journal of Chinese Materia Medica 2011;36(14):1855-1859
OBJECTIVETo investigate the alteration of inflammasome and receptor during IgG promoter transfected to HepG2 cells.
METHODBy assay of Elisa to evaluate the secretion of IL-1 beta, IL-8, TNF-alpha and MCP-1 after puerarine and LPS administration, and by assay of real time PCR to evaluate the expression of mRNA of IL-1 beta, IL-8,TNF-alpha and MCP-1, as well as the receptors of TLR2, 4 and NOD2, MyD88.
RESULTIgG promoter did not active innate immunity and enhance the expression and secretion of inflammasome in HepG2. Puerarine did not active the inflammasome either. LPS activated the innate immunity and increased the secretion of IL-8, TNF-alpha and MCP-1.
CONCLUSIONIgG-HepG2 cells could be used specifically as the model of allergy type II for ingredients screening. It is suggested that puerarine was suite for the activator for this type of allergy as positive control.
Allergens ; analysis ; immunology ; Drugs, Chinese Herbal ; chemistry ; Gene Expression Regulation ; immunology ; Hep G2 Cells ; Humans ; Immunity, Innate ; immunology ; Immunoglobulin G ; genetics ; Inflammasomes ; immunology ; Promoter Regions, Genetic ; genetics ; Transfection
7.Effect of NLRP3 inflammasome on vascular diseases.
Zeng CAO ; Yapei LI ; Ruifang CHEN ; Pingyu ZENG
Journal of Central South University(Medical Sciences) 2016;41(11):1232-1236
The NLRP3 inflammasome, a protein complex belonging to the family of nucleotide-binding and oligomerization domain like receptors (NLRs), plays a vital role in the innate immune system. It promotes pro-caspase 1 cleavage into active caspase-1, which contributes to maturation and releases of IL-1β and IL-18 in response to the harmful signals and participates in the host immune response and sterile inflammation. Recently a large number of studies have shown that NLRP3 inflammasome closely relates to the pathogenesis of the vascular diseases. NLRP3 inflammasome, which involves in the sterile inflammation of the vascular wall, plays an important role in the pathogenesis of main, middle and small arteries.
Caspase 1
;
immunology
;
metabolism
;
Gene Expression Regulation
;
genetics
;
immunology
;
Humans
;
Inflammasomes
;
immunology
;
Inflammation
;
complications
;
genetics
;
Interleukin-18
;
genetics
;
immunology
;
Interleukin-1beta
;
genetics
;
immunology
;
NLR Family, Pyrin Domain-Containing 3 Protein
;
immunology
;
Signal Transduction
;
genetics
;
immunology
;
Vascular Diseases
;
etiology
;
genetics
;
immunology
8.Molecular regulative mechanisms of NLRP3 inflammasome activation in diabetic nephropathy and interventional effects of Chinese herbal medicine.
Wen-Wen WANG ; Wen-Bei HAN ; Yi-Gang WAN ; Yue TU ; Bu-Hui LIU ; Ying-Lu LIU ; Wei WU ; Hong-Yun YEE ; Qi-Jun FANG ; Jian YAO
China Journal of Chinese Materia Medica 2020;45(1):7-13
The progression of renal damage in diabetic nephropathy(DN)is closely related to Nod-like receptor protein3(NLRP3)inflammasome activation. The characteristics of NLRP3 inflammasome activation include the changed expression and combination levels of NLRP3, apoptosis-associated speck-like protein(ASC)and pro-caspase-1, the increased expression levels of caspase-1, interleukin(IL)-1β and IL-18 and the excessive release levels of the relative inflammatory mediators. Its molecular regulative mechanisms involve the activation of multiple signaling pathways including reactive oxygen species(ROS)/thioredoxin-interacting protein(TXNIP)pathway, nuclear factor(NF)-κB pathway, nuclear factor erythroid-related factor 2(Nrf2)pathway, long non-coding RNA(lncRNA)pathway and mitogen-activated protein kinases(MAPKs)pathway. In addition, more importantly, never in mitosis aspergillus-related kinase 7(Nek7), as a kinase regulator, could target-combine with NLRP3 at upstream to activate NLRP3 inflammasome. Some extracts of Chinese herbal medicines(CHMs)such as quercetin, curcumin, cepharanthine, piperine and salidroside, as well as Chinese herbal compound prescriptions such as Wumei Pills both could treat NLRP3 inflammasome to ameliorate inflammatory renal damage in DN. Therefore, accurately clarifying the targets of anti-inflammatory CHMs and Chinese herbal compound prescriptions delaying DN progression by targeting the molecular regulative mechanisms of NLRP3 inflammasome activation will be one of the development directions in the future.
Caspase 1/immunology*
;
Diabetes Mellitus/drug therapy*
;
Diabetic Nephropathies/immunology*
;
Drugs, Chinese Herbal/therapeutic use*
;
Humans
;
Inflammasomes/immunology*
;
Interleukin-18/immunology*
;
Interleukin-1beta/immunology*
;
NIMA-Related Kinases
;
NLR Family, Pyrin Domain-Containing 3 Protein/immunology*
9.NLRP3 Inflammasome and Host Protection against Bacterial Infection.
Journal of Korean Medical Science 2013;28(10):1415-1423
The inflammasome is a multi-protein complex that induces maturation of inflammatory cytokines interleukin (IL)-1beta and IL-18 through activation of caspase-1. Several nucleotide binding oligomerization domain-like receptor family members, including NLRP3, recognize unique microbial and danger components and play a central role in inflammasome activation. The NLRP3 inflammasome is critical for maintenance of homeostasis against pathogenic infections. However, inflammasome activation acts as a double-edged sword for various bacterial infections. When the IL-1 family of cytokines is secreted excessively, they cause tissue damage and extensive inflammatory responses that are potentially hazardous for the host. Emerging evidence has shown that diverse bacterial pathogens or their components negatively regulate inflammasome activation to escape the immune response. In this review, we discuss the current knowledge of the roles and regulation of the NLRP3 inflammasome during bacterial infections. Activation and regulation of the NLRP3 inflammasome should be tightly controlled to prevent virulence and pathology during infections. Understanding the roles and regulatory mechanisms of the NLRP3 inflammasome is essential for developing potential treatment approaches against pathogenic infections.
Bacterial Infections/immunology/metabolism/pathology/prevention & control
;
Carrier Proteins/*metabolism
;
Caspase 1/metabolism
;
Humans
;
Inflammasomes/immunology/*metabolism
;
Interleukin-1beta/metabolism
;
Signal Transduction
10.NOD-Like Receptors in Infection, Immunity, and Diseases.
Young Keun KIM ; Jeon Soo SHIN ; Moon H NAHM
Yonsei Medical Journal 2016;57(1):5-14
Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are pattern-recognition receptors similar to toll-like receptors (TLRs). While TLRs are transmembrane receptors, NLRs are cytoplasmic receptors that play a crucial role in the innate immune response by recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). Based on their N-terminal domain, NLRs are divided into four subfamilies: NLRA, NLRB, NLRC, and NLRP. NLRs can also be divided into four broad functional categories: inflammasome assembly, signaling transduction, transcription activation, and autophagy. In addition to recognizing PAMPs and DAMPs, NLRs act as a key regulator of apoptosis and early development. Therefore, there are significant associations between NLRs and various diseases related to infection and immunity. NLR studies have recently begun to unveil the roles of NLRs in diseases such as gout, cryopyrin-associated periodic fever syndromes, and Crohn's disease. As these new associations between NRLs and diseases may improve our understanding of disease pathogenesis and lead to new approaches for the prevention and treatment of such diseases, NLRs are becoming increasingly relevant to clinicians. In this review, we provide a concise overview of NLRs and their role in infection, immunity, and disease, particularly from clinical perspectives.
Autophagy/immunology
;
Carrier Proteins
;
Humans
;
*Immunity, Innate
;
Inflammasomes
;
Nod Signaling Adaptor Proteins/immunology/*metabolism
;
Pathogen-Associated Molecular Pattern Molecules
;
Receptors, Cytoplasmic and Nuclear/immunology/*metabolism
;
Receptors, Pattern Recognition/*immunology
;
*Signal Transduction
;
Toll-Like Receptors/metabolism